Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Cysteamine (topical) wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Shared outcomes (1)
Outcomes where both Alpha-Arbutin and Cysteamine (topical) have evidence — compare verdict strength side-by-side.
Topical cosmetic only. Alpha-arbutin is typically used at roughly 1-2% in leave-on serums, applied to areas of hyperpigmentation once or twice daily, usually alongside daily sunscreen and often with other brighteners. There is no oral, injectable, or systemic dose — it is not ingested. This library does not provide an ingestion protocol.
any
Leave-on topical serum (≈1-2% alpha-arbutin)
Topical cosmetic. Cysteamine 5% cream is typically applied once daily to areas of melasma as a short-contact treatment (left on for ~15 minutes, then washed off) to limit odor and irritation, with daily sunscreen. There is no oral or systemic use in this context. This library does not provide an ingestion protocol.
any
Cysteamine 5% cream (short-contact application)
Throughout
8-12 weeks
Throughout
Throughout
Throughout
8-16 weeks
Throughout
Throughout
The Efficacy of Topical Cosmetic Containing Alpha-Arbutin 5% and Kojic Acid 2% Compared With Triple Combination Cream for the Treatment of Melasma: A Split-Face, Evaluator-Blinded Randomized Pilot Study.
J Cosmet Dermatol (2025) · Rct · n=30
Split-face, evaluator-blinded randomized pilot in 30 melasma patients: alpha-arbutin 5% + kojic acid 2% vs triple-combination cream over 12 weeks
Efficacy and Safety of a Topical Formulation Containing Trihydroxybenzoic Acid Glucoside and α-Arbutin, Applied Along With a Sunscreen: A Noncomparative, Prospective, Interventional Study in Indian Females With Facial Melasma or Dark Spots.
J Cosmet Dermatol (2025) · Open label · n=124
Open-label, single-arm 90-day study in 124 Indian women using alpha-arbutin 2% + trihydroxybenzoic acid glucoside twice daily plus once-daily sunscreen
Inhibitory effects of alpha-arbutin on melanin synthesis in cultured human melanoma cells and a three-dimensional human skin model.
Biol Pharm Bull (2004) · In vitro
Foundational mechanism study: alpha-arbutin reduced melanin synthesis in cultured human melanoma cells (to 76% at 0.5 mM) and to 40% of control in a 3D human skin model
Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial.
Br J Dermatol (2015) · Rct · n=50
First double-blind placebo-controlled RCT of cysteamine 5% cream for epidermal melasma (n=50), nightly for 4 months
Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a new measurement method: a randomized double blind placebo controlled study.
J Dermatolog Treat (2018) · Rct · n=40
Second double-blind placebo-controlled RCT (n=40), nightly cysteamine 5% for 4 months, with Dermacatch and Mexameter colorimetry
A comparative study of topical 5% cysteamine versus 4% hydroquinone in the treatment of facial melasma in women.
Int J Dermatol (2020) · Rct · n=40
Multicenter evaluator-blinded head-to-head of cysteamine 5% vs hydroquinone 4% (n=40), nightly for 120 days with sunscreen
Cysteamine (topical) has a higher evidence score (6/10 vs 4/10) and wins in 2 of 3 categories.
For even skin tone, Cysteamine (topical) has a higher relevance score (70 vs 60).
No known interactions between Alpha-Arbutin and Cysteamine (topical) have been documented in our database. However, always consult a healthcare provider before combining supplements.